Newark-based ANP Technologies Inc. received Emergency Use Authorization for its rapid Covid-19 test from the Food and Drug Administration, The test, which provides a visible result in 15 minutes, is based on ANP's technology. The test is sensitive in the detection of nasal swab specimens. In addition to its 95% detection rate during clinical testing, [...] The post Newark company's rapid Covid-19 test gets FDA emergency approval appeared first on Delaware Business Now.
